Literature DB >> 16373930

Summary of revisions for the 2006 Clinical Practice Recommendations.

.   

Abstract

Mesh：

Year:  2006        PMID： 16373930

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  Reweighted Mahalanobis distance matching for cluster-randomized trials with missing data.

Authors:  Robert A Greevy; Carlos G Grijalva; Christianne L Roumie; Cole Beck; Adriana M Hung; Harvey J Murff; Xulei Liu; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-05       Impact factor: 2.890

Review 2.  Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Authors:  Merlin C Thomas; Robert C Atkins
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  A Methodological Description of a Randomised Controlled Trial Comparing Hospital-Based Care and Hospital-Based Home Care when a Child is Newly Diagnosed with Type 1 Diabetes.

Authors:  Irén Tiberg; Annelie Carlsson; Inger Hallström
Journal:  Open Nurs J       Date:  2011-11-18

Review 4.  Management of hypertension in the cardiometabolic syndrome and diabetes.

Authors:  Nitin Khosla; Peter Hart; George L Bakris
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 5.430

5.  NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy.

Authors:  Jianbo Li; Hongman Zhang; Min Xie; Lingfei Yan; Jiawei Chen; Hongxing Wang
Journal:  Diabetes Care       Date:  2013-07-11       Impact factor: 19.112

6.  Fibrinogen function indexes are potential biomarkers of diabetic peripheral neuropathy.

Authors:  Yong Zhuang; Xiahong Lin; Xiaoyu Chen; Xiaohong Wu; Jinying Zhang
Journal:  Diabetol Metab Syndr       Date:  2022-01-18       Impact factor: 3.320
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.